| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/02/2003 | EP1268776A2 Corneodesmosin based test and model for inflammatory disease |
| 01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268762A1 Novel nucleic acids and polypeptides |
| 01/02/2003 | EP1268761A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 01/02/2003 | EP1268760A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 01/02/2003 | EP1268759A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 01/02/2003 | EP1268756A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/02/2003 | EP1268755A1 Method to identify polypeptides with protease activity |
| 01/02/2003 | EP1268750A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 01/02/2003 | EP1268746A2 PRODUCTION OF TcR GAMMA DELTA T CELLS |
| 01/02/2003 | EP1268744A2 Rickettsia felis outer membrane protein |
| 01/02/2003 | EP1268555A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 01/02/2003 | EP1268554A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 01/02/2003 | EP1268549A2 Method of identifying inhibitors of tie-2 |
| 01/02/2003 | EP1268548A2 Regulation of human rta-like g protein-coupled receptor |
| 01/02/2003 | EP1268547A2 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 01/02/2003 | EP1268546A2 G protein-coupled receptors |
| 01/02/2003 | EP1268545A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268542A2 Therapeutic anti-melanoma compounds |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268539A2 Estrogen-regulated unconventional myosin-related protein: compositions and methods of use |
| 01/02/2003 | EP1268538A2 Human secreted proteins and polynucleotides encoding the same |
| 01/02/2003 | EP1268537A1 Crystal structure of the (aml1 runt domain)/(cbfbeta) heterodimer and the ternary complex with dna |
| 01/02/2003 | EP1268535A2 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can be used in the treatment of the above disease states and identification of a nematode gene. |
| 01/02/2003 | EP1268534A2 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy |
| 01/02/2003 | EP1268533A2 Novel invertase inhibitors and methods of use |
| 01/02/2003 | EP1268532A2 Human t cell response to mhc-binding motif clusters |
| 01/02/2003 | EP1268531A2 Method for the production of bacterial toxins |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268529A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 01/02/2003 | EP1268528A2 Human genes and expression products |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268526A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/02/2003 | EP1268524A2 Binding peptides for carcinoembryonic antigen (cea) |
| 01/02/2003 | EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 01/02/2003 | EP1268521A1 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268520A2 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268515A1 Process for preparing coagulants for water treatment |
| 01/02/2003 | EP1268514A2 Methods for purifying highly anionic proteins |
| 01/02/2003 | EP1268512A2 A computer based method for identifying conserved invariant peptide motifs |
| 01/02/2003 | EP1268510A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268509A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 01/02/2003 | EP1267934A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 01/02/2003 | EP1267911A1 A method of treatment |
| 01/02/2003 | EP1267910A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 01/02/2003 | EP1267909A1 Methods of blocking tissue destruction by autoreactive t cells |
| 01/02/2003 | EP1267908A1 Vaccine for the treatment of atherosclerosis |
| 01/02/2003 | EP1267907A1 Use of mia in immunotherapy |
| 01/02/2003 | EP1267904A2 Polypeptoid pulmonary surfactants |
| 01/02/2003 | EP1267899A2 Salmonella vaccine materials and methods |
| 01/02/2003 | EP1267860A1 Butylnitrone containing compositions for inhibition of cancer development |
| 01/02/2003 | EP1267627A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof |
| 01/02/2003 | EP1238058A4 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 01/02/2003 | EP1169433A4 Human hac3 |
| 01/02/2003 | EP1127259A4 Thromboplastin reagents and methods for preparing and using such reagents |
| 01/02/2003 | EP1105428A4 Novel cleaved fragments of fibrinogen |
| 01/02/2003 | EP1100949A4 Fusion products containing insoluble proteinaceous tag |
| 01/02/2003 | EP1078040A4 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/02/2003 | EP1073452B1 Use of deltorphin for treating cytokine mediated hepatic injury |
| 01/02/2003 | EP0981368A4 Mass spectrometry of colonization factors |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/02/2003 | EP0948526A4 Contryphan peptides |
| 01/02/2003 | EP0910574B1 Method for discovering novel anthelmintic compounds |
| 01/02/2003 | EP0885244B1 Peptide immunogens for vaccination against and treatment of allergy |
| 01/02/2003 | EP0854725B1 Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | EP0740504B1 Phytophthora resistance gene of catharanthus and its use |
| 01/02/2003 | EP0725081B1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 01/02/2003 | EP0628074B1 In vitro activation of cytotoxic t cells |
| 01/02/2003 | EP0625988B1 Allosteric modulators of the nmda receptor |
| 01/01/2003 | CN1388248A Adenovirus proliferated specifically inside tumor cell to express interferon in high efficiency and its construction method |
| 01/01/2003 | CN1388134A Recombined clathrate protein, its producing process, noble metal-recombined clathrate protein compound, its producing process and recombined DNA |
| 01/01/2003 | CN1388133A Method of utilizing biosynthesis and chemical modification technology in producing thymic hormone al monomer |
| 01/01/2003 | CN1388132A Cell death inducing protein and its coding sequence and use |
| 01/01/2003 | CN1388131A Serial medicine carriers, tyrosine hydrozylase fusion protein as new carrier and its prepn |
| 01/01/2003 | CN1388130A Human hematopoietic cell relating gene-1 |
| 01/01/2003 | CN1097633C Determinating, purifying and testing for rhabdovirus of ichthyophthirius |
| 01/01/2003 | CN1097468C Products containing G-CSF and TNF binding protein |
| 12/31/2002 | USRE37952 Grb3-3 cDNA and polypeptides |
| 12/31/2002 | US6501009 Expression of Cry3B insecticidal protein in plants |
| 12/31/2002 | US6501007 Inhibiting expression of an rna transcription product of the d1 gene of given sequence using an antisense oligonucleotide; controlling daikoku type dwarfism gene d1 expression |
| 12/31/2002 | US6501006 Nucleic acids conferring chilling tolerance |
| 12/31/2002 | US6501003 Mouse transformed with a humanized mutant of green fluorescent protein operably linked to the glial fibrillary acidic protein promoter; use determining the neurotoxicity of a substance |
| 12/31/2002 | US6500945 Nucleotides having chiral phosphorus linkages |
| 12/31/2002 | US6500942 Rin2, a novel inhibitor of Ras-mediated signaling |
| 12/31/2002 | US6500941 Secreted by human breast cancer mda-mb-175 cells, leads to the formation of a constitutive active receptor complex and stimulates these cells in an autocrine manner |
| 12/31/2002 | US6500940 Apoptotic-associated polypeptide lifeguard (lfg); use to treat disorder associated with increased or decreaase fas-mediated cell death |
| 12/31/2002 | US6500939 Human homologue of the rat protein translocation protein sec61-alpha subunit, which plays a role in protein transport across the endoplasmic reticulum; use as probes for the gene diagnosis, gene sources for gene therapy and drug screening |
| 12/31/2002 | US6500937 Plasmid or vector; sequence encodes mammastatin; useful in the diagnosis and treatment of breast cancer |
| 12/31/2002 | US6500934 Bivalent agonists for G-protein coupled receptors |
| 12/31/2002 | US6500933 Methods of preparing carbohydrate crosslinked glycoprotein crystals |
| 12/31/2002 | US6500930 Hemoglobin-polysaccharide conjugates |
| 12/31/2002 | US6500929 Protein containing a functional domain of a water-soluble c1 inhibitor and an anchor molecule; suppressing complement activity; membrane bound complement regulatory proteins; transplantation |
| 12/31/2002 | US6500928 Mammalian cytokine-like factor 7 |